Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray
Clinical trial NCT05248373 · UNKNOWN
Trial details
- NCT number
- NCT05248373
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2023-02-14
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.